Page 26 - Express Scripts News Today

Successful drug importation from Tier 1 countries (Canada, Australia, United Kingdom) has existed in the U.S. for 20 years. Drug fulfillment in Canada mirrors the U.S. process.

The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to

The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to

The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to

The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to

A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.

The Utah Attorney Generals Office filed a lawsuit against insulin manufacturers on Thursday accusing them of what it calls an unconscionable insulin pricing scheme.

The Biden administration's new limits on pharmacy benefit managers, set to take effect next year, are expected to have negative impacts on pharmacies. The Biden administration’s first major step toward imposing limits on pharmacy benefit managers is backfiring, pharmacists say.

Several employees of drug middleman Express Scripts last year raked in bonuses of $750,000 each for getting the business of a managed-care company that depends on Medicaid for the bulk of its business.

As reported by our local CBS affiliate, Alexandria, Va., is suing PBMs and drug manufacturers in federal court over what it is calling a “conspiracy” that has pushed drug prices up — particularly for certain insulins — by more than 1,000 percent over the last 25 years.